Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A truncated protein linked to breast cancer may change cell adhesion.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

The gel is a safe and effective treatment for hyperpigmentation.

CTCF protein is essential for skin and hair follicle development in mice.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Vitamin D receptor and mediator 1 are crucial for healthy skin and hair growth.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

FTase and GGTase-I are essential for skin keratinocyte health.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.